Bauckneht, M.; Rebuzzi, S.E.; Signori, A.; Donegani, M.I.; Murianni, V.; Miceli, A.; Borea, R.; Raffa, S.; Damassi, A.; Ponzano, M.;
et al. The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study. Cancers 2020, 12, 3213.
https://doi.org/10.3390/cancers12113213
AMA Style
Bauckneht M, Rebuzzi SE, Signori A, Donegani MI, Murianni V, Miceli A, Borea R, Raffa S, Damassi A, Ponzano M,
et al. The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study. Cancers. 2020; 12(11):3213.
https://doi.org/10.3390/cancers12113213
Chicago/Turabian Style
Bauckneht, Matteo, Sara Elena Rebuzzi, Alessio Signori, Maria Isabella Donegani, Veronica Murianni, Alberto Miceli, Roberto Borea, Stefano Raffa, Alessandra Damassi, Marta Ponzano,
and et al. 2020. "The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study" Cancers 12, no. 11: 3213.
https://doi.org/10.3390/cancers12113213
APA Style
Bauckneht, M., Rebuzzi, S. E., Signori, A., Donegani, M. I., Murianni, V., Miceli, A., Borea, R., Raffa, S., Damassi, A., Ponzano, M., Catalano, F., Martelli, V., Marini, C., Boccardo, F., Morbelli, S., Sambuceti, G., & Fornarini, G.
(2020). The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study. Cancers, 12(11), 3213.
https://doi.org/10.3390/cancers12113213
